Please wait while the formulary information is being retrieved.
CHLORASEPTIC TOTAL (DEXTROMETHORPHAN HBR/BENZOCAINE/MENTHOL)
- Cough
- Sore throat
- Mouth irritation
5 mg-6 mg-10 mg lozenges
- Dosage information is not available
- Azilect
- Eldepryl
- isocarboxazid
- linezolid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- rasagiline
- selegiline HCl
- tranylcypromine
- Zelapar
- Zyvox
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Systemic mastocytosis
Severe
Moderate
- None
CHLORASEPTIC TOTAL (DEXTROMETHORPHAN HBR/BENZOCAINE/MENTHOL)
- Cough
- Sore throat
- Mouth irritation
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Vomiting
Less Severe
- Abdominal pain with cramps
- Dizziness
- Drowsy
- Nausea
Contraindicated
Benzocaine (Oral,muc memb)
Increased risk for developing methemoglobinemia. Avoid use in infant or child age < 2 years.
Do not use in pediatrics <6 years of age unless clinician consultation.
- 1 Day – 2 Years
- 1 Increased risk for developing methemoglobinemia. Avoid use in infant or child age < 2 years.
- 1 Day – 6 Years
- 1 Increased risk for developing methemoglobinemia. Avoid use in infant or child age < 2 years.
Dextromethorphan (OTC)
Increased risk for developing methemoglobinemia. Avoid use in infant or child age < 2 years.
Do not use in pediatrics <6 years of age unless clinician consultation.
- 1 Day – 2 Years
- 1 Do not use in pediatrics <6 years of age unless clinician consultation.
- 1 Day – 6 Years
- 1 Do not use in pediatrics <6 years of age unless clinician consultation.
Severe Precaution
Benzocaine (Oral,muc memb)
Increased risk for developing methemoglobinemia. Consult clinician prior to use.
- 2 Years – 6 Years
- Increased risk for developing methemoglobinemia. Consult clinician prior to use.
Management or Monitoring Precaution
None
Dextromethorphan
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Benzocaine
Reports of infant methemoglobinemia after ingestion of topical benzocaine
Insufficient data available; molecular wt low enough for possible excretion
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | No adverse effect | Reports of infant methemoglobinemia after ingestion of topical benzocaine |
Dextromethorphan
Reports of infant methemoglobinemia after ingestion of topical benzocaine
Insufficient data available; molecular wt low enough for possible excretion
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available; molecular wt low enough for possible excretion |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Select Anesthetics
General-May be more sensitive to CNS and cardiac adverse reactions. Consider dose reduction due to reduced clearance in the elderly.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | Y | Y | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Cough | |
| R05 | Cough |
| Mouth irritation | |
| K13.79 | Other lesions of oral mucosa |
| Sore throat | |
| R07.0 | Pain in throat |
| 0-9 | A-Z |
|---|---|
| K13.79 | Other lesions of oral mucosa |
| R05 | Cough |
| R07.0 | Pain in throat |
Formulary Reference Tool